Hyperliquid Strategies INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Hyperliquid Strategies Inc. has amended its ChEF Purchase Agreement with Chardan Capital Markets LLC, altering the terms for future share purchases.
Hyperliquid Strategies Inc. has amended its ChEF Purchase Agreement with Chardan Capital Markets LLC, adjusting the pricing for future share sales.
Hyperliquid Strategies Inc. has amended its purchase agreement with Chardan Capital Markets LLC, increasing the total commitment to $2.5 billion and enhancing its financial resources.
Hyperliquid Strategies Inc. announced robust financial and operational results for fiscal year 2026, marked by a substantial increase in its HYPE token treasury, significant equity capital raise, and expansion within the Hyperliquid ecosystem.
Hyperliquid Strategies Inc. has entered into a new executive placement agreement for its COO and amended its CEO's employment contract.
Hyperliquid Strategies Inc. reported a significant net loss for Q2 2025, primarily driven by unrealized losses on HYPE tokens, despite strong balance sheet and strategic capital deployment.
Hyperliquid Strategies Inc. announced a new stock repurchase program of up to $30 million, aiming to enhance shareholder value by increasing per-share exposure to the HYPE token.
Hyperliquid Strategies Inc. has completed its business combination with Sonnet BioTherapeutics and Rorschach I LLC, pivoting to a digital asset treasury model focused on the HYPE token and listing on Nasdaq under 'PURR'.